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The Ehlers-Danlos syndromes (EDS) are a group of 13 disorders, clinically defined
through features of joint hypermobility, skin hyperextensibility, and tissue fragility. Most
subtypes are caused by mutations in genes affecting the structure or processing of
the extracellular matrix (ECM) protein collagen. The Hypermobility Spectrum Disorders
(HSDs) are clinically indistinguishable disorders, but are considered to lack a genetic
basis. The pathogenesis of all these disorders, however, remains poorly understood.
Genotype-phenotype correlations are limited, and findings of aberrant collagen fibrils
are inconsistent and associate poorly with the subtype and severity of the disorder.
The defective ECM, however, also has consequences for cellular processes. EDS/HSD
fibroblasts exhibit a dysfunctional phenotype including impairments in cell adhesion and
cytoskeleton organization, though the pathological significance of this has remained
unclear. Recent advances in our understanding of fibroblast mechanobiology suggest
these changes may actually reflect features of a pathomechanism we herein define. This
review departs from the traditional view of EDS/HSD, where pathogenesis is mediated
by the structurally defective ECM. Instead, we propose EDS/HSD may be a disorder
of membrane-bound collagen, and consider how aberrations in cell adhesion and
cytoskeleton dynamics could drive the abnormal properties of the connective tissue,
and be responsible for the pathogenesis of EDS/HSD.
Keywords: Ehlers-Danlos syndrome, hypermobility spectrum disorder, fibroblasts, integrins, cytoskeleton,
mechanobiology
INTRODUCTION
The Ehlers-Danlos syndromes (EDS) are a group of heritable connective tissue disorders defined
by the presence of three clinical features: joint hypermobility, skin hyperextensibility, and tissue
fragility (Malfait et al., 2017). The condition is named after two dermatologists, Edvard Lauritz
Ehlers and Henri-Alexandre Danlos both of whom independently characterized some of the
first clinical descriptions of EDS in the early 20th Century (Parapia and Jackson, 2008). The
formal categorization of the EDS subtypes began in the 1960s, and there have since been several
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reclassifications following advances in our understanding of the
molecular and genetic basis of these disorders (Table 1). Most
subtypes have now been shown to be caused by mutations in
genes affecting the structure or processing of collagen (Malfait
et al., 2017). Most recently, the International Consortium on the
ehlers-danlos syndromes proposed updated diagnostic criteria
in 2017, which recognizes 13 different EDS subtypes (Malfait
et al., 2017). Since its publication, a 14th subtype of EDS
has been identified (Blackburn et al., 2018). While provisional
diagnoses can be made based on clinical major and minor
criteria, a definitive diagnosis now relies on the molecular
identification of the causative variant(s) in the respective gene.
The exception lies with the hypermobile form of EDS (hEDS;
formerly EDS type III) which, despite being the most common
form, remains as the only subtype without an identified
distinct genetic variation, and whose diagnosis remains clinical
alone. In addition, it is important to recognize the related
Hypermobility Spectrum Disorders (HSD) which are clinically
indistinguishable from hEDS, and both diagnoses are often
termed together as hEDS/HSD. HSD is a diagnosis the EDS
consortium had intended to reflect patients who demonstrate
the characteristic feature of hEDS, i.e., joint hypermobility, but
lack sufficient clinical evidence to demonstrate a genetic aetiology
to their presentation. The segregation of these diagnoses was
intended to produce a more homogenous cohort to further
aid research efforts to identify the genetic markers of hEDS,
but does not differentiate patients in terms of severity of
symptoms or disability (Tinkle et al., 2009; Copetti et al., 2019).
Collectively, EDS/HSD has a diagnosed prevalence of 1 in 500
(Demmler et al., 2019).
Our current understanding of EDS/HSD pathogenesis is
informed by the two best characterized subtypes, the classical
(cEDS) and vascular (vEDS) forms, which are consequent to
mutations in genes encoding the minor collagen proteins, type
V (Symoens et al., 2012), and type III (Pepin et al., 2000),
respectively. Mutations either cause haploinsufficiency, which is
a 50% reduction in protein expression caused by a nonsense-
mediated decay of the non-viable RNA transcript (Leistritz
et al., 2011; Symoens et al., 2012), or the production of a
structurally defective procollagen molecule which is retained
within the endoplasmic reticulum (Smith et al., 1997; Symoens
et al., 2012). Consequently, in both scenarios, the absence of
sufficient functional minor collagen proteins in the extracellular
matrix (ECM) then impedes with their role in regulating the
formation and organization of the major type I collagen into
fibrils (Figure 1; Liu et al., 1997; Wenstrup et al., 2004a,b; D’hondt
et al., 2018; Wang et al., 2020). This disrupts the integrity of the
ECM and is assumed to be the underlying cause of connective
tissue weakness.
However, this notion is not truly reflected in transmission
electron microscopy (TEM) analyses of collagen fibril structure
and organization in EDS/HSD skin biopsies, though general
abnormalities can be found. These abnormalities include reduced
and disorganized collagen bundles with abnormal orientations,
or non-circular cross-sections of collagen fibrils that are
described as “flower-like,” or with variable diameters both larger
and smaller than would be typically expected (Holbrook and
Byers, 1982; Hausser and Anton-Lamprecht, 1994; Hermanns-
Lê and Piérard, 2006). vEDS patients have been characterized as
having collagen fibrils that are smaller and more variable, and
with an overall reduced density (Smith et al., 1997), while cEDS is
associated with the presence of flower-like collagen fibrils (Vogel
et al., 1979; de Moraes et al., 2000; Bowen et al., 2017; Angwin
et al., 2020).
Yet, these findings are not consistent and this should be
considered significant. It has long been noted that the degree of
ultrastructural changes observed do not correlate with clinical
severity (Proske et al., 2006), or presentation (Kobayasi, 2004;
Hermanns-Lê et al., 2012). Further studies have shown that
patients can present with no significant collagen abnormalities,
despite a clinical presentation and/or confirmation of genetic
disorder. In 2019, one study reported two individuals with a
likely pathogenic variant of the COL5A1 gene that did not
present with the typical collagen flowers expected (Angwin
et al., 2019), contradicting a consensus previously reached by
the EDS committee in 2017 (Bowen et al., 2017). Another study
in vEDS patients found that the size of collagen fibers and
bundle characteristics did not discriminate between vEDS and
control participants, nor did all vEDS participants present with
abnormal fibril diameters (Ong et al., 2012). More recently, a
larger study of 177 EDS patients found that no specific TEM
finding could be associated with any specific EDS subtype
(Angwin et al., 2020). Remarkably, from the 177 patients with
a clinical diagnosis, 147 (83%) had a normal TEM report, and
from the 24 patients with a genetic confirmation of their subtype,
7 (29%) also had a normal biopsy report (Angwin et al., 2020).
Conversely, it has been demonstrated that clinically unaffected
family members and control participants can also present with
the same EDS-associated ultrastructural abnormalities without
displaying features of a connective tissue disorder (Kobayasi,
2004; Hermanns-Lê et al., 2012). As such, the only conclusion
that can be derived from these collective TEM studies is that an
abnormal biopsy finding is more frequently found in EDS/HSD
patients (Angwin et al., 2020).
These findings demonstrate that despite the categorization of
EDS/HSD as a disorder of collagen, the reported ultrastructural
collagen abnormalities do not appear to be the principal
mediators of abnormal connective tissue properties in these
disorders. It is therefore plausible to assume that other related
factors heavily influence connective tissue properties and mediate
the EDS/HSD phenotype. One such factor may be the cellular
mechanics of fibroblasts, the predominant cell type that populates
the connective tissue.
THE ROLE OF FIBROBLASTS IN
MEDIATING THE PROPERTIES OF THE
CONNECTIVE TISSUE
The ability of fibroblasts to directly exert force and influence
the tension in the surrounding environment is significant, as
it directly affects the viscoelastic properties of the connective
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Genetic basis Protein OMIM condition
Classical EDS (cEDS) EDS Classical Type Gravis (EDS type I) COL5A1 Type V collagen 130000
Mitis (EDS type II) COL5A2 130010
** ** COL1A1 Type I collagen –
Classical-like EDS (clEDS)
type 1
** ** TNXB Tenascin XB 606408





Cardiac-valvular (cvEDS) ** ** COL1A2 Type I collagen 225320
Vascular EDS (vEDS) EDS Vascular Type Arterial-ecchymotic (EDS
type IV)
COL3A1 Type III collagen 130050
** ** COL1A1 Type I collagen –
Hypermobile EDS (hEDS) EDS Hypermobility Type Hypermobile (EDS type III) Unknown Unknown 130020
Arthrochalasia (aEDS) EDS Arthrochalasia Type Arthrochalasis multiplex
congenita (EDS type VIIA)
COL1A1 Type I collagen 130060
** Arthrochalasis multiplex
congenita (EDS type VIIB)
COL1A2 Type I collagen 617821
Dermatosparaxis EDS
(dEDS)





Kyphoscoliotic EDS (kEDS) EDS Kyphoscoliosis Type Ocular-Scoliotic (EDS type
VIA)
PLOD1 Lysyl hydroxylase 1 225400





** Ocular-Scoliotic (EDS type
VIB)
ZNF469 Zinc finger protein
469
229200










** ** B3GALT6 β3GalT6 615349
** ** SLC39A13 ZIP13 612350
Musculocontractural EDS
(mcEDS)
** ** CHST14 Dermatan-4
sulfotransferase-1
601776
** ** DSE Dermatan sulfate
epimerase-1
615539
Myopathic EDS (mEDS) ** ** COL12A1 Type XII collagen 616471
Periodontal EDS (pEDS) Other forms (Periodontal
type)






























*Removed as an EDS subtype from the criteria.
**Unidentified or unrecognized EDS subtype at time of criteria formation.
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FIGURE 1 | The formation and function of collagen fibrils in connective tissue. Fibroblasts secrete collagen molecules into the ECM which associate in a staggered
pattern to form collagen fibrils. These collagen fibrils consist mostly of the major collagen protein, type I, while the minor collagen proteins, such as type III and type V
constitute only a fraction of fibril mass (Theocharidis and Connelly, 2019). The importance of these minor collagens, however, lies in their role in regulating the
diameter and organization of collagen fibrils. In the example of type V collagen molecules, the presence of a non-collagenous domain which projects outwards
introduces steric hindrances when incorporated within collagen fibrils (Wenstrup et al., 2004a). This limits the lateral growth of the fibrils and may also play a role in
regulating their diameter (Wenstrup et al., 2004a). Multiple collagen fibrils together form collagen fibers which provide tensile strength to the connective tissue. The
absence of sufficient amounts of minor collagen proteins, like in EDS, can result in poorly formed collagen fibrils, and in turn, collagen fibers (Theocharidis and
Connelly, 2019). The tissue specific expression and roles of the minor collagen proteins presumably accounts for the characteristic presentation of each specific EDS
subtype, all of which differ in the varying presence, manifestation, and degrees of joint hypermobility, skin hyperextensibility, and tissue fragility. Image created with
BioRender.com.
tissue. This has been demonstrated through gel contraction
assays (Figure 2) (Dallon and Ehrlich, 2008). Fibroblasts seeded
into isolated and recombinant collagen gels generate tractional
forces by cytoskeleton contractility which propagate throughout
the gel matrix. This compacts the collagen fibrils, eliminating
water from between the fibrils which decreases the gel volume.
The contraction of this gel is proposed to reflect the ability of
fibroblasts to contract an open wound, hence this is used as the
typical model assay for the study of cell-ECM interactions in the
context of wound healing.
Such gel contraction assays have provided several relevant
findings of note. Firstly, the ability of fibroblasts to contract
the gel significantly, demonstrates how the cellular mechanics
of fibroblasts can directly influence the material properties
of their environment, e.g. the connective tissue (Delvoye
et al., 1991; Eastwood et al., 1994, 1996). These assays have
also demonstrated the key cellular features enabling gel
contraction. One is cell adhesion to collagen via integrins,
as blocking integrin-mediated adhesion with antibodies
prevented gel contraction (Klein et al., 1991; Schiro et al.,
1991; Kelynack et al., 2000). Equally important is an active
cytoskeleton, as using molecular inhibitors that interfere with
actin filament and microtubule polymerization abrogates
tractional force generation and reduces tension within the gel
(Kolodney and Wysolmerski, 1992; Swierczewski et al., 2016;
Giannopoulos et al., 2018). The involvement of intermediate
filaments has also been indicated in this process, as vimentin-
null fibroblasts show a reduced ability to contract the gel
(Ridge et al., 2016).
However, the significance of these findings is not just/limited
to the context of wound healing, but reflect important processes
involved in the ongoing maintenance of connective tissue
function. It has been shown that fibroblasts do not simply
contract the gel when seeded, but they alter their cytoskeletal
contractility to adapt to any external loads applied in order
to maintain an overall resting tension in the environment
(Delvoye et al., 1991; Brown et al., 1998; Mizutani et al., 2004;
Giannopoulos et al., 2018; Zollinger et al., 2018). Indeed, the
specific level of resting tension established by fibroblasts has
been described as a “tensile setpoint”, and their tendency to
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FIGURE 2 | Principles underlying collagen gel contraction assays. Standard gel contraction assays involve seeding fibroblasts into a collagen gel solution and
allowing the suspension to polymerize. The freshly polymerized gel is placed in media for a set time period and allowed to contract. Changes in the diameter of the
gel are measured before and after and can be used as a parameter to quantify cell contractility. Image created with BioRender.com.
actively maintain this equilibrium as “tensional homeostasis”
(Brown et al., 1998). Furthermore, it has been shown that
the ability to maintain tensional homeostasis is not dependent
on the stiffness of the environment, and is only limited by
the load force not the displacement (Freyman et al., 2002).
This suggests that healthy fibroblasts are also capable of
compensating for a materially weak ECM by adjusting the
level of contractile force needed to maintain overall normal
levels of resting tension (Tomasek et al., 2002). Experiments on
mouse subcutaneous connective tissue have also reproduce these
findings in a more physiological setting. Stretching connective
tissue samples caused a disproportionate change in fibroblast
morphology, which could not be explained by simple passive
spreading of cells, but indicated an active response (Langevin
et al., 2005, 2011). The importance of active processes in
mediating tensional homeostasis was shown when inducing
cell death or inhibiting cytoskeleton dynamics increased the
tension within the connective tissue by 60-80% upon stretch
(Langevin et al., 2011).
These findings indicate that fibroblast mechanics play a
significant role in mediating the properties of the connective
tissue beyond the context of wound healing. Fibroblasts actively
alter their contractile forces in response to everyday mechanical
strains and loads for the purposes of maintaining appropriate
tension, hence, also determining the viscoelastic properties of the
connective tissue. Furthermore, these processes are dependent on
the key processes of cell adhesion and cytoskeleton dynamics.
Impairments in any of these processes, therefore, may affect
connective tissue integrity and viscoelasticity, and contribute to
the pathogenesis of EDS/HSD.
Indeed, fibroblast dysfunction has been implicated in the
pathogenesis of several other connective tissue disorders.
Fibroblasts from patients with floppy eyelid syndrome, a
hyperelasticity disorder affecting the upper eyelid, demonstrate
a significantly higher tensile setpoint compared to control
(Ezra et al., 2010). In Dupuytren’s contracture, a condition
affecting the facia of the hand, fibroblasts are unable to respond
appropriately to mechanical loading, and exert an opposite
response and of a greater magnitude compared to control
fibroblasts, something which also disturbed the attainment of
tensional homeostasis (Bisson et al., 2004, 2009). Of particular
significance are findings from Pelvic Organ Prolapse (POP)
patients, a condition of weakened connective tissue highly
associated with EDS/HSD (Carley and Schaffer, 2000; Lammers
et al., 2012). Under static conditions, POP fibroblasts in cell
culture demonstrate a significantly higher expression of the
cytoskeleton proteins actin, α-tubulin, and vimentin compared
to control cells, indicating an increased mechano-response
to the stiff substrate of a culture dish (Wang et al., 2015).
In response to mechanical strain, however, POP fibroblasts
exhibit a significant decrease in the expression of actin, in
contrast to control cells that increased actin expression under
the same conditions (Wang et al., 2015). Another study also
found that POP fibroblasts delayed the alignment of their
actin cytoskeleton in the direction of the force in response
to mechanical strain compared to control cells (Ruiz-Zapata
et al., 2013). These findings indicate that POP fibroblasts
are unable to efficiently respond to mechanical forces, which
may even overload and impair the integrity of cytoskeletal
system. In the context of a whole tissue environment, such a
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failure would contribute to the weakening of the connective




CHANGES IN CELL ADHESION AND
CYTOSKELETON ORGANIZATION
The culturing of fibroblasts derived from the dermal biopsies
of EDS/HSD patients have revealed several relevant molecular
changes (Zoppi et al., 2018b; Chiarelli et al., 2019), including
an altered integrin expression profile that is shared amongst the
main EDS/HSD subtypes (Zoppi et al., 2018b). Integrins are
cell surface receptors composed of one α and one β subunit,
giving rise to 24 unique integrins which play a central role in
cell adhesion, cell signaling, and cell survival (Barczyk et al.,
2010). Integrins mediate the attachment between the cell and
specific ECM proteins like collagen or fibronectin (Figure 3).
Binding of the ECM ligand exposes the cytoplasmic tail of the
integrin, which provides a scaffold to allow recruitment of paxilin,
vinculin, talin, and other proteins during the formation of multi-
protein complexes called focal adhesions constituting signaling
complexes (Kanchanawong et al., 2010; Parsons et al., 2010).
These in turn, regulate the activity of the Rho family of GTPases,
which act as molecular switches to regulate downstream signaling
processes and cytoskeleton organization (Kanchanawong et al.,
2010; Parsons et al., 2010). These adhesion sites act as a strong
anchoring point for the actin cytoskeleton, important for the
mechanical feedback between cell and ECM.
The integrin profile demonstrated in EDS/HSD involves the
downregulation of the collagen receptor, α2β1 integrin, as well
as the fibronectin receptor, α5β1 integrin, while the vitronectin
receptor, αvβ3 integrin, is upregulated instead. In EDS/HSD,
this αvβ3 integrin functions as an alternative receptor for
fibronectin (Zoppi et al., 2018b). The expression of this specific
integrin profile is termed the “integrin switch” (Zoppi et al.,
2004, 2018b), which can be recreated in control cells with a
functional blocking of the α2β1 receptor (Zoppi et al., 2004).
This demonstrates that the absence of a structurally organized
collagen in the ECM failing to engage with its receptor α2β1
leads to the altered integrin expression profile. This, in turn,
will influence other cellular processes that may be critical in the
pathogenesis EDS/HSD.
The first of these is mechano-sensitivity, which is an ability
of fibroblasts to sense the compliance of their environment and
the strain present within it (Schwartz, 2010). This process would
be essential to produce the appropriate cytoskeletal response to
mechanical strain and requires the cooperative actions of various
integrins. A study demonstrating such cooperation of integrins
with different mechanosensitive roles showed the α5β1 integrins
to be implicated in force generation, whereas αv-class integrins
mediated the structural adaptations to forces (Schiller et al.,
2013). Fibroblasts in which the interaction between the αvβ3
integrin and fibronectin is blocked, also failed to sense the rigidity
of a fibronectin matrix (Jiang et al., 2006). This would suggest
that the integrin switch would alter the mechano-sensing ability
of EDS/HSD fibroblasts. Indeed, there is already some indication
that this process is perturbed in hEDS/HSD. When hEDS/HSD
fibroblasts were cultured on a stiff culture substrate, excessive
actin stress fibers could be observed compared to control
(Zoppi et al., 2018a), however, these were absent in hEDS/HSD
fibroblasts that were directly observed within tissue samples
(Celli et al., 2020). This demonstrates that excessive stress fiber
formation is not a persistent feature of hEDS/HSD fibroblasts, but
instead, could be reflective of mechano-sensitivity aberrations. It
is possible that this abnormal cytoskeletal response only occurred
when fibroblasts adhered to stiff substrates in vitro, but not when
they remained within their native soft tissue environment. Such
mechano-sensitivity aberrations are physiologically relevant, as
conditions of mechanical strain can temporarily stiffen the
environment of fibroblasts in vivo, and, similarly, produce an
abnormal cytoskeletal response which contributes to abnormal
connective tissue properties.
The integrin switch may also impair cell-ECM adhesion,
which may be crucial for tissue integrity. Indeed, aberrant
adhesion has already been demonstrated in EDS/HSD. In
cEDS and vEDS fibroblasts, cell-ECM adhesion has been
shown to be mediated specifically between the αvβ3 integrin
and fibronectin, whereas control cells show no such critical
dependency (Zoppi et al., 2008). The fibronectin organization
itself is impaired in EDS/HSD, present only as rare fibrils in the
ECM (Zoppi et al., 2018b), further indicating a compromised
cell-ECM interaction. The strength of the cell-ECM adhesions
themselves, may also be limited. A single bond between the
α2β1 integrin and collagen can withstand a mechanical force
of 160 pN (Niland et al., 2011), whereas bonds between
α5β1 and fibronectin begin to break at 30 pN (Kong et al.,
2009). Bonds between αvβ3 and fibronectin break at even lower
forces (Roca-Cusachs et al., 2009). This was demonstrated in a
study where adhesion between cells and fibronectin-coated beads
was mediated either by the αvβ3 integrin or α5β1. Following
application of a 1 nN force for 100 s, cells adhering via αvβ3
completely detached from the beads, whereas cells adhering via
the α5β1 integrin maintained adhesion (Roca-Cusachs et al.,
2009). The same differences in adhesion strength were also
observed when clustering of the integrins was promoted (Roca-
Cusachs et al., 2009). It is suggested that these weaker αvβ3
bonds facilitate force detection by breaking more easily, and
hence, their role is to enable mechano-transduction rather
than adhesion. Consequently, these collective findings suggest
that the integrin switch, alongside the defective fibronectin
organization observed in EDS/HSD, may produce far weaker
connections between the cell and ECM. These may break more
easily under conditions of mechanical strain, and contribute
to the weakening of the integrity of the connective tissue
(Roca-Cusachs et al., 2009).
Some impairments in the cytoskeleton of EDS/HSD fibroblasts
have also been observed in vitro. cEDS and vEDS fibroblasts
demonstrate a disorganized actin cytoskeleton (Zoppi et al.,
2008), whereas in hEDS and HSD, the actin cytoskeleton is
organized into stress fibers (Zoppi et al., 2018a). Furthermore,
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FIGURE 3 | Integrins serve as a vital connection between the cells’ internal cytoskeleton and the ECM. Integrins span the membrane of fibroblasts, with vital
intracellular and extracellular domains. Binding of the ECM ligand (collagen, fibronectin etc.) to the extracellular domain leads to the activation of the integrin, and a
conformational change in its cytoplasmic tail. This triggers a rapid recruitment of adaptor proteins such as talin and paxillin to the cytoplasmic tail, which in turn,
triggers a signaling cascade involving the Rho GTPases. These act as molecular switches to regulate the polymerization of actin, and hence, play an important role in
determining the cytoskeletons contractility. The lateral assembly or “clustering” of integrins also occurs upon ligand binding, to form multi-protein complexes termed
“focal adhesions” at the cell surface. These act as strong anchoring points and mediate the specific attachment between the cell cytoskeleton and the ECM. Image
created with BioRender.com.
cEDS and vEDS fibroblasts show a decreased migratory
capacity (Viglio et al., 2008; Zoppi et al., 2018a), whereas
cell migration is significantly increased in hEDS and HSD
fibroblasts (Zoppi et al., 2018a). This migratory capacity is
relevant, as it involves the same mechanical machinery that
generates the tractional forces implicated in mediating tensional
homeostasis (Pollard and Borisy, 2003; Webster et al., 2014).
These findings indicate that this aspect of EDS/HSD fibroblast
function may also be aberrant and contribute to abnormal
connective tissue properties.
The integrin switch itself may also have further implications
for cytoskeleton dynamics. Integrins are also known to
influence the activities of the Rho-GTPases, RhoA, Rac1,
and Cdc42, which are crucial to cell protrusion formation
(Lawson and Burridge, 2014), which in turn, is involved
in the tensional homeostasis mechanism (Webster et al.,
2014). During this process, the initial extension of the
plasma membrane is driven predominantly through Rac-
mediated actin polymerization, while RhoA and Cdc42 activity
contributes to extension of cell protrusions at later stages
of cell spreading (Ridley, 2015). It has been demonstrated
that β1 integrin subunit in particular, is required to support
RhoA activation at later stages of cell spreading (Danen
et al., 2002). Overexpression of the β3 subunit has also been
shown to enhance the activity of RhoA and promote stress
fiber formation, whereas overexpression of the β1 subunit
enhanced Rac activity and cell protrusion formation (Miao
et al., 2002). In another study examining cell migration in
epithelial cells, adhesion via αvβ3 was shown to support
extensive actin cytoskeletal reorganization and the formation
of a single broad protrusion at the leading edge, whereas cell
adhesion via α5β1 caused the extension of thinner protrusions
(Danen et al., 2005). These findings indicate that the integrin
profile demonstrated in EDS/HSD cells, may also have direct
consequences on the ability of fibroblasts to form and/or
maintain cell protrusions under conditions of mechanical strain
and maintain connective tissue tension.
ASSESSING DERMATOSPARAXIS AND
EDS FIBROBLAST DYSFUNCTION
THROUGH GEL CONTRACTION ASSAYS
It is clear from the molecular changes described that fibroblast
dysfunction is to be expected in EDS/HSD, involving aberrations
in both cell adhesion and cytoskeleton dynamics. This has
been directly examined in gel contraction studies performed
with fibroblasts from animals with dermatosparaxis, which
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is equivalent to the human form of dermatosparaxis EDS
(dEDS; formerly EDS type VIIC) (Colige et al., 1999).
This disorder is caused by mutations in the ADAMTS2
gene, which encodes the procollagen N-proteinase enzyme,
and consequently results in poorly structured and loosely
arranged collagen fibrils in the ECM (Bavinton et al., 1985).
However, similarly, to the ongoing discrepancies in human
EDS/HSD studies, the TEM findings of aberrant collagen
fibrils in dermatosparaxis animals do not appear to reflect
severity of presentation, and therefore, fail to fully account
for and explain the abnormal properties of the connective
tissue (Bavinton et al., 1985). The gel contraction abilities,
however, do more accurately reflect clinical presentation.
Dermal fibroblasts from mildly affected sheep demonstrate a
gel contraction profile approaching that of control dermal
fibroblasts (Ramshaw et al., 1991), while those from severely
affected calf and sheep failed to contract the gel (Delvoye
et al., 1983, 1986, 1991; Ramshaw et al., 1991). Furthermore,
fibroblasts obtained from the less affected tissues in the severely
presenting calf, like the tendons, vena cava, and aorta, also
reflect this tissue specific presentation, and contracted the
gel, similarly, to control fibroblasts (Delvoye et al., 1983).
These finding are highly significant, as the correlation of
fibroblast dysfunction with severity of manifestation, both
between differently presenting animals, and between tissues
within the same animal, likely demonstrates one of the main
pathomechanisms mediating the observed connective tissue
abnormalities. This provides confirmation that dysfunction of
the fibroblast does indeed, constitute a relevant pathomechanism
for EDS/HSD, and one that has now been demonstrated in a
relevant animal model.
The nature of the fibroblasts inability to contract the gel
was later shown to be due to the cell surface absence of
a 34 kDa collagen binding protein related to anchorin CII
(Mauch et al., 1988), which prevented effective cell adhesion of
dermatosparatic fibroblasts to collagens type I and IV (Mauch
et al., 1986). Consequently, it appears these fibroblasts were
unable to attach to the type I collagen in the gel and effectively
mediate the cytoskeletal forces needed to contract the collagen
gel, as well as maintain homeostatic levels of tension within a
restrained gel (Delvoye et al., 1991). These findings, therefore,
confirm that impaired cell adhesion is a significant feature
of fibroblast dysfunction, reducing integrity of the connective
tissue integrity.
These findings highlight the complexity that underlies
monogenic disorders. Pathogenesis of dermatosparaxis in this
case, may not have been principally mediated by the aberrant
collagen molecule itself, but mediated by a reduced cell
surface expression of a cell adhesion molecule, that initially
appears unrelated to the underlying ADAMTS2 mutation. This
demonstrates that far more complex cellular and molecular
processes underlie the pathway from initial mutated gene
to final pathogenic phenotype and is likely to involve the
interplay of various independent environmental and related
factors. These independent factors could influence critical
pathogenic features, and either promote a less or more severe
phenotype in the affected individuals, which may help to
explain the vast heterogeneity seen in the presentation of
these disorders.
The same gel contraction studies were also performed
with human EDS samples at the time, however, they
demonstrated unexpected results. Fibroblasts from patients
of several EDS subtypes showed no gel contraction
abnormalities and behaved similar to control fibroblasts
(Delvoye et al., 1986, 1991). Remarkably, this also
included dEDS, which has an identical genetic basis to
dermatosparaxis. It was concluded from these studies that
fibroblast dysfunction did not contribute to the pathogenesis
of human EDS/HSD, and research into this pathomechanism
discontinued as focus turned toward identifying further
EDS-related genes.
However, this conclusion now appears contradictory to our
molecular understanding of EDS/HSD. The α2β1 integrin is
the main collagen receptor in humans and plays the equivalent
role to the anchorin CII-related protein in mediating the
attachment between the cell and collagen. The α2β1 integrin is
also downregulated in EDS/HSD fibroblasts as part of the integrin
switch (Zoppi et al., 2018b). Furthermore, several gel contraction
studies performed in control cells while blocking the collagen-
α2β1 interaction, prevented contraction of the gel (Klein et al.,
1991; Schiro et al., 1991; Kelynack et al., 2000). These findings
all highly indicate that the integrin switch seen in EDS/HSD
fibroblasts should result in similar impairments in cell-ECM
adhesion and prevent gel contraction, while also reflecting their
pathological behavior in vivo.
Our understanding of the mechanisms regulating these
molecular processes has also progressed. It is now apparent
that these gel contraction assays do not truly reflect the
EDS/HSD scenario in humans specifically, and hence, the drawn
conclusions may not be valid. It has since been demonstrated
that adding relevant collagen to the media of cultured human
EDS fibroblasts promotes phenotypic correction, which reverses
the integrin switch and restores the expression of α2β1 to
the cell surface (Zoppi et al., 2004). As such, the collagen
supplied in these gel contraction assays may have corrected
the phenotype of human EDS fibroblasts, and restored the
cell surface expression of α2β1. This would have promoted
normal gel contraction, yet not reflect the true in vivo behavior
of EDS/HSD fibroblasts. Hence, the human equivalent of this
pathomechanism cannot be demonstrated through standard
gel contraction assays. The existence of this pathomechanism
therefore, has not been excluded in human patients, nor has it
yet been truly examined.
DISCUSSION
This review had the aim to highlight a potential
pathomechanism in EDS/HSD involving fibroblast dysfunction.
Three principal stages of this pathomechanism can be
described (Figure 4).
The first is a failed interaction between collagen and
its receptor, the α2β1 integrin (Zoppi et al., 2018b). The
underlying cause of this failed interaction is specific for
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FIGURE 4 | The three principal stages of the proposed pathomechanism for EDS/HSD. (1) A failed interaction between collagen and α2β1: A disorganized or
defective collagen-ECM prevents engagement of the collagen ligand with its receptor, the α2β1 integrin, and triggers the integrin switch. (2) The integrin switch:
Fibroblasts respond to the defective collagen-ECM by switching their cell adhesion profile to promote adhesion to other ECM ligands. The α2β1 and α5β1 integrins
are downregulated, and αvβ3 is upregulated, which then mediates the attachment between cell and ECM via fibronectin. (3) Fibroblast dysfunction: The altered
integrin profile also has various consequences for the fibroblasts phenotype, which affects its ability to implement the tensional homeostasis mechanism and
maintain integrity of the connective tissue. Impaired cell-ECM adhesion may promote fragility of the connective tissue. Impairments in mechanosensitivity may cause
an incorrect interpretation of tension within the connective tissue and facilitate an abnormal cytoskeleton response. Aberrations in the dynamic cytoskeleton
response itself, may also facilitate abnormalities in the viscoelastic properties of the connective tissue. All such aspects may contribute to the EDS/HSD phenotype.
Image created with BioRender.com.
each EDS subtype, and can easily be accounted for in
the genetically characterized subtypes of EDS. In cEDS and
vEDS for example, mutations in the minor collagen genes
prevent the organization of type I collagen into fibrils, which
prevents its engagement with α2β1 (Zoppi et al., 2018b). In
hEDS and HSD, though the principle underlying molecular
defect is unknown, an enhanced expression of the matrix
metalloproteinase (MMP), MMP-9, has been observed (Zoppi
et al., 2018a). The proteolytic activity of MMP-9 could
promote a general disassembly of the ECM, and in turn,
prevent the engagement of collagen with α2β1. This stage
of the pathomechanism, however, also allows the possibility
of an acquired EDS phenotype, consequent to any other
disease processes that interferes with collagen-α2β1 binding.
Speculatively, any autoimmune or inflammatory condition
that promotes a general disassembly of collagen in the
ECM could initiate the same pathomechanism and promote
connective tissue abnormalities, which then manifest through
features of joint hypermobility, skin hyperextensibility, and
tissue fragility.
The second stage of the pathomechanism involves the
integrin switch itself, which is a shared feature of the
main EDS/HSD subtypes (Zoppi et al., 2018b). Following
the failed collagen-α2β1 interaction, a downregulation of
the α2β1 integrin itself occurs, which is accompanied by
a downregulation of the fibronectin receptor α5β1, and an
upregulation of the alternative fibronectin receptor αvβ3. It is
possible that fibroblasts are able to sense the compromised
collagen-ECM via the α2β1 integrin, and recognize a potential
risk of anoikis, a specific form of cell death that occurs
upon cell detachment from the ECM. To avoid such a
fate, it is possible that fibroblasts respond by switching
their integrin profile to promote cell adhesion to other
ECM ligands, such as fibronectin, in order to maintain
some form of attachment to the ECM and survive. Indeed,
this notion is supported by apoptosis assays performed in
cEDS and vEDS fibroblasts, where the αvβ3 integrin was
specifically shown to rescue EDS cells from anoikis (Zoppi
et al., 2008), indicating that this integrin switch is indeed,
a critical cell survival response. The importance of cell-ECM
adhesion, however, extends beyond the transmission of cell
survival signals, and we have described in this review its
importance in maintaining connective tissue integrity. The
integrin switch, therefore, may form a key stage of this
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pathomechanism, due to the consistent nature of this finding
across all of the main EDS/HSD subtypes, as well as the
critical consequences in weakening cell-ECM adhesion and its
contribution to overall fibroblast dysfunction.
The final stage of this pathomechanism is fibroblast
dysfunction itself, which ultimately mediates the abnormal
properties of the connective tissue. The critical features of this
dysfunction are impairments in cell adhesion and cytoskeleton
dynamics. As already described, impaired cell-ECM adhesion
weakens the integrity of the connective tissue, however, it
also prevents fibroblasts from mediating their cytoskeletal
forces to the surrounding environment and implement the
tensional homeostasis mechanism. The integrin switch itself,
has also been shown to directly affect cytoskeleton dynamics,
impairing the cytoskeletal forces that are transferred through
the weakened cell-ECM adhesions. The integrin switch may
also cause abnormalities in the mechanosensitivity of fibroblasts,
which may prevent accurate interpretations of the surrounding
ECM properties, and hence, may produce an inappropriate
response by fibroblasts. As such, key connective tissue properties
such as viscoelasticity and integrity are all affected consequent
the integrin switch and may contribute to the pathogenesis
of EDS/HSD.
The contribution of this specific pathomechanism to the
overall EDS/HSD phenotype could potentially be significant.
It has to be highlighted that the current TEM analyses of
collagen fibril structure and organization in EDS/HSD are highly
inconsistent, and fail to associate with any EDS subtype, specific
connective tissue abnormality, or severity of the manifestation
(Angwin et al., 2020). Indeed, even the most significant
abnormality associated with EDS/HSD, in the form of collagen
flowers in cEDS, is one that cannot explain the disproportionate
changes in skin viscoelasticity seen in this subtype, and is also
one that is found in unaffected individuals (Hermanns-Lê et al.,
2012). To our knowledge, the studies into fibroblast mechanics
in dermatosparaxis animals, are the only non-genetic findings to
have correlated with severity of connective tissue manifestation
(Delvoye et al., 1983; Ramshaw et al., 1991), yet the possible
significance of this appears to have been overlooked.
These findings suggest that what unites and defines the
EDS/HSD subtypes may not be defects in the structure and/or
organization of collagen itself, but in cell adhesion to collagen. If
such a notion is correct, this may provide an ideal basis for
the development of a universal or non-specific diagnostic test
that truly captures all EDS/HSD subtypes, irrespective of the
principal underlying defect. An assessment for membrane-bound
collagen for example, would highly indicate that cell-ECM
adhesion has switched in vivo from collagen to other ECM
ligands, reflecting the occurrence of the initial stages of this
pathomechanism in patients presenting with connective tissue
ailments. This is of importance, since the most common forms of
hEDS and HSD, are currently without any diagnostic biomarker,
and it is likely that further unidentified subtypes remain.
This may also have implications for other related disorders
such as fibromyalgia, and Myalgic Encephalomyelitis/Chronic
Fatigue Syndrome (ME/CFS), which demonstrate significant
overlaps with hypermobility and connective tissue abnormalities,
though the association is poorly understood (Bragée et al.,
2020; Eccles et al., 2020). It is plausible therefore, that similar
pathomechanisms involving fibroblast dysfunction may be
contributing to the pathogenesis of these related disorders, which
could be explored through their associations with membrane-
bound collagen.
Of additional importance is to determine if this
pathomechanism contributes to arterial fragility in vEDS, a
lethal subtype of EDS with a median life expectancy of 40 years
(Eagleton, 2016). Death commonly occurs due to complications
associated with spontaneous vascular or hollow organ ruptures,
however, the development of these are also poorly understood
(Eagleton, 2016). If such a pathomechanism demonstrates itself
to be significant, the development of a therapeutic agent that
promotes arterial integrity via these processes could provide hope
for a number of patients.
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